ZHANG Xiu-Mei, CAI Jing, YANG Ya-Nan, CHEN Xue-Si, XIE Xu-Ming. PREPARATION AND CHARACTERIZATION OF PLGA/TiO2 NANO DRUG DELIBERY CARRIERS. [J]. Acta Polymerica Sinica (6):653-660(2011)
DOI:
ZHANG Xiu-Mei, CAI Jing, YANG Ya-Nan, CHEN Xue-Si, XIE Xu-Ming. PREPARATION AND CHARACTERIZATION OF PLGA/TiO2 NANO DRUG DELIBERY CARRIERS. [J]. Acta Polymerica Sinica (6):653-660(2011) DOI: 10.3724/SP.J.1105.2011.10154.
PREPARATION AND CHARACTERIZATION OF PLGA/TiO2 NANO DRUG DELIBERY CARRIERS
A novel biodegradable PLGA/TiO2 organic-inorganic hybrid nano-material was prepared by the reaction between activated carboxyl-terminated PLGA
which was synthesized by PLGA and succinic anhydride with TEA as catalyzer
and amino-terminated TiO2 nano-particles which were modified by amino propyltriethoxysilane (KH550).The structure and morphology of the materials were characterized by Fourier transform infrared spectroscopy (FTIR)
1H nuclear magnetic resonance (1H-NMR)
thermogravimetic analysis (TGA)
environmental scanning electron microscopy (ESEM) and transmission electron microscopy (TEM) methods.The results showed that the PLGA was grafted successfully on the surface of nano scale TiO2 particles with 14% average grafting; PLGA/TiO2 hybrid nano-material dispersed uniformly in BSA aqueous solution without obvious aggregation and showed a better adsorptivity (81.3%) to model drug BSA as compared with that(43.3%) of pure TiO2 nanoparticles.Different kinds of the nanopaticles containing proteins BSA (TiO2-BSA and PLGA/TiO2-BSA) were loaded into polymer microspheres with PLGA as carrier by the solid-in-oil-in-water emulsion method.The drug loading content
entrapment efficiency and drug release in vitro of different drug containing microspheres were tested.The results indicated that the microspheres of PTB/P showed smooth morphologies
high entrapment efficiency 96% and drug loading content 14.6% and decreased burst effect of drug
compared with TB/P microspheres.
关键词
纳米二氧化钛PLGA有机-无机杂化药物缓释
Keywords
TiO2 nano-particlesPLGAOrganic-inorganic hybridDrug control release